| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-08-24 |
4 |
AS |
$9.90 |
$2,673 |
D/D |
(270) |
43,720 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-11-23 |
4 |
AS |
$10.49 |
$2,832 |
D/D |
(270) |
42,777 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-02-18 |
4 |
AS |
$10.49 |
$2,853 |
D/D |
(272) |
110,348 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$4,839 |
D/D |
(277) |
111,344 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-05-23 |
4 |
AS |
$12.09 |
$3,385 |
D/D |
(280) |
110,345 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-05-26 |
4 |
AS |
$12.45 |
$3,536 |
D/D |
(284) |
50,404 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$4,706 |
D/D |
(284) |
48,955 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-02-28 |
4 |
AS |
$13.85 |
$3,933 |
D/D |
(284) |
55,078 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-05-26 |
4 |
AS |
$19.20 |
$5,453 |
D/D |
(284) |
98,750 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-11-28 |
4 |
AS |
$14.97 |
$4,251 |
D/D |
(284) |
96,108 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-02-28 |
4 |
AS |
$14.90 |
$4,232 |
D/D |
(284) |
104,164 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-11-29 |
4 |
AS |
$15.22 |
$4,338 |
D/D |
(285) |
47,509 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-08-26 |
4 |
AS |
$16.08 |
$4,599 |
D/D |
(286) |
97,426 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-09-15 |
4 |
AS |
$10.54 |
$3,141 |
D/D |
(298) |
43,047 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-11-21 |
4 |
AS |
$15.01 |
$4,488 |
D/D |
(299) |
96,701 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-05-20 |
4 |
AS |
$18.55 |
$5,584 |
D/D |
(301) |
99,341 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-12-15 |
4 |
AS |
$11.16 |
$3,370 |
D/D |
(302) |
42,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-02-23 |
4 |
AS |
$15.09 |
$4,557 |
D/D |
(302) |
52,747 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$4,732 |
D/D |
(302) |
98,019 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-05-24 |
4 |
AS |
$18.69 |
$5,738 |
D/D |
(307) |
99,034 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-02-23 |
4 |
AS |
$13.26 |
$4,084 |
D/D |
(308) |
55,362 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-11-23 |
4 |
AS |
$15.20 |
$4,697 |
D/D |
(309) |
47,794 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-11-23 |
4 |
AS |
$14.97 |
$4,626 |
D/D |
(309) |
96,392 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-08-24 |
4 |
AS |
$15.22 |
$4,718 |
D/D |
(310) |
49,239 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$6,761 |
D/D |
(312) |
99,068 |
0 |
- |
|
167 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
